News
Companies are not yet rushing to relocate production to the US, but investment and dealmaking have already slowed ...
Second, SoFi could grow its revenue even without expanding its membership base, by cross-selling additional products to its ...
Merck & Co., Inc. (NYSE:MRK) ranks among the best set-it-and-forget-it stocks to buy. On June 27, TD Cowen maintained its ...
From health to hair care, the experts broke down exactly how artificial intelligence is shaping Black futures and why we can’t afford to sit this one out.
In Hazle Twp. on the end of a road in Humboldt Industrial Park, Michaels Stores wants to make its distribution center part of ...
Demand fell 1.4 per cent from the previous month in May, the statistics office said on July 4. Read more at straitstimes.com.
11h
The Manila Times on MSNAstraZeneca eyes licensing lung cancer drugASTRAZENECA is in talks with Summit Therapeutics to license an experimental lung-cancer drug under a deal worth as much as $15 billion, Bloomberg News reported on Thursday, citing people familiar with ...
13h
Zacks Investment Research on MSNWill Novo Nordisk's Rare Disease Bets Reduce GLP-1 Reliance?Novo Nordisk NVO has experienced remarkable growth in recent years, largely fueled by the commercial success of its ...
Merck’s stock fell 1.77% to $80.93 while the market gained, despite rising 5.26% over the past month. The company’s upcoming ...
16h
BirminghamWorld on MSNCuriosity Cube brings hands-on science to Birmingham, inspiring the next generation of scientistsFor the fourth consecutive year, the Curiosity Cube — a mobile science lab designed to make STEM (science, technology, ...
The European Commission has cleared OD-L1 inhibitor Imfinzi (durvalumab) to treat adults with resectable muscle-invasive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results